Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Total expenses | 142 | 155 | 300 | 137 | 662 |
| Operating Income | -142 | -155 | -300 | -137 | -662 |
| Interest Expense | 8 | 11 | 13 | 11 | 26 |
| Other Income | 0 | 0 | 5 | -11 | 0 |
| Pre-tax Income | -150 | -166 | -308 | -158 | -689 |
| Net Income Continuous | -150 | -166 | -308 | -158 | -689 |
| Net Income | $-150 | $-166 | $-308 | $-158 | $-689 |
| EBITDA(a) | $-136 | $-146 | $-289 | $-128 | $-643 |